Penile Traction Therapy FAQ: Your Questions Answered

Penile traction therapy is a non-surgical medical treatment that applies controlled, sustained mechanical force to the penis using a calibrated traction device — commonly called a penis extender or penis stretcher. The therapy works through mechanotransduction — the biological process by which cells convert mechanical strain into new tissue growth. Dr. Jørn Ege Siana, plastic surgeon and co-inventor, and Danamedic ApS of Denmark invented penile traction in 1994, and the method has since been validated by 15+ peer-reviewed clinical studies. For a complete overview, see the penile traction therapy guide.

Penile traction devices — also known as penis extenders — apply calibrated tension of 900–2,800 grams (8.8–27.5 Newtons) along the penile shaft for 4–6 hours per day. This sustained force triggers mechanotransduction at the cellular level, stimulating the reorganization and remodelling of collagen fibres within the tunica albuginea. Over 3–6 months, this process produces measurable tissue elongation — making penile traction the only evidence-based non-surgical penis enlargement method. The mechanism is the same biological principle used in orthopedic limb lengthening and tissue expansion surgery.

Yes — penile traction therapy produces statistically significant length gains confirmed by multiple independent clinical studies. The 2023 meta-analysis by Almsaoud, Safar, and Alshahrani (PMID: 36895692) calculated a weighted mean gain of 1.9 cm across twelve pooled studies. A 2021 randomized controlled trial by Toussi et al. (PMID: 34060339) demonstrated 1.6 cm vs 0.3 cm in the control group (p<0.01) among 82 men. For detailed study analysis, see clinical studies and evidence for penile traction therapy.

Penile traction therapy treats three primary clinical indications: (1) short penile length, with documented gains of 1.3–2.3 cm over 3–6 months; (2) Peyronie's disease, where Levine et al. (PMID: 18373527) demonstrated curvature reduction and length preservation; and (3) post-surgical penile shortening, including after prostatectomy. Peyronie's disease affects 3–9% of adult men, and traction is recommended as a conservative treatment option in urological guidelines.

Adult men seeking non-surgical penile lengthening, men diagnosed with Peyronie's disease, and men experiencing post-surgical shortening are good candidates for penile traction therapy. Ideal candidates can commit to the daily 4–6 hour wear protocol for 3–6 months. Men with active genital infections, bleeding disorders, or penile implants should not use traction devices without direct urological supervision. For a detailed candidacy assessment, see who should use penile traction therapy.

Penile traction therapy is supported by 15+ peer-reviewed studies published in journals including the Journal of Sexual Medicine, Translational Andrology and Urology, and BJU International. The 2023 Almsaoud meta-analysis (PMID: 36895692) represents the highest level of clinical evidence — a systematic review pooling 12 studies and over 1,000 patients. This body of research distinguishes penile traction therapy from unproven methods. For a guide to reading the research, see understanding clinical studies on penile traction.

Yes — penile traction therapy demonstrates a favorable safety profile when performed with a properly calibrated medical device. Across 15+ peer-reviewed clinical studies, no serious adverse events have been reported. The mild adverse event rate is 11.2–14.4%, consisting of temporary discomfort, skin irritation, or minor bruising that resolves after adjustment. For the complete safety analysis, see penile traction therapy safety and side effects.

Reported side effects are mild and temporary: skin redness or irritation at contact points, minor discomfort during initial adjustment, occasional bruising, and temporary numbness. These occur in 11.2–14.4% of users and resolve with device adjustment or brief rest periods. No long-term complications, no permanent tissue damage, and no cases of erectile dysfunction have been attributed to traction therapy in peer-reviewed studies.

Injury risk is extremely low when using an FDA-registered Class II medical device with calibrated tension settings. Clinical studies report no serious injuries. Risk increases substantially with unregulated devices, DIY contraptions, or hanging weights — none of which provide controlled, calibrated force. Medical-grade penile traction devices are engineered with tension limiters and comfort systems to prevent excessive force application.

Contraindications include active genital infection or inflammation, bleeding disorders or anticoagulant therapy, penile prosthetic implants, open wounds or recent surgery in the treatment area, and priapism. Men with erectile dysfunction should consult a urologist before starting traction, as the underlying cause may require separate treatment. Penile traction therapy is not recommended for men under 18.

Follow the manufacturer's protocol: start at lower tension (900–1,200 grams) and increase gradually over the first two weeks. Never exceed the device's maximum rated tension. Take a 10–15 minute break every 2 hours. Remove the device immediately if you experience pain, numbness, or skin color changes. Use only medical-grade devices with calibrated tension settings — never improvised weights or homemade devices.

Most clinical studies report measurable gains within 3–6 months of consistent daily use. Gontero et al. (PMID: 19138361) documented a mean gain of 1.3 cm at 6 months. Nikoobakht et al. (PMID: 20102448) reported 1.7 cm gain in both flaccid and stretched states. Earlier gains may be visible by week 8–12, but full results require the complete treatment duration. For detailed timelines, see how long to see results from penile traction therapy.

Clinical protocols prescribe 4–6 hours of daily wear for optimal results. The Toussi et al. RCT (PMID: 34060339) used a 4–6 hour daily protocol and achieved 1.6 cm mean gain in the treatment group. Adherence is critical — the Almsaoud meta-analysis documented an 82% adherence rate across studies, and patients who maintained consistent daily use achieved the best outcomes. Wear time can be split across multiple sessions throughout the day. For protocol details, see how long to see results from penile traction therapy.

Penile traction therapy produces a mean length gain of 1.3–2.3 cm (0.5–0.9 inches) over 3–6 months based on published clinical data. The 2023 Almsaoud meta-analysis confirmed a 1.9 cm weighted mean gain. Individual results depend on adherence, baseline anatomy, and daily wear duration. In the Toussi RCT, 87% of patients said they would repeat treatment and 93% would recommend it to others. For a realistic assessment, see does penile traction therapy really work.

Most clinical protocols last 3–6 months, with some extending to 9 months for Peyronie's disease treatment. Gontero et al. used a 6-month protocol; the Toussi et al. RCT (PMID: 34060339) also demonstrated significant gains. After the initial treatment period, some practitioners recommend a maintenance phase of 1–2 hours daily for several additional weeks to help consolidate tissue remodeling gains. Consult your healthcare provider for personalized treatment duration guidance.

Penile traction therapy can complement certain other treatments under medical supervision. Levine et al. (PMID: 18373527) studied traction in combination with Peyronie's disease management, finding curvature reduction and length preservation. Some clinicians combine traction with vacuum erection devices or PDE5 inhibitors for post-prostatectomy rehabilitation. Never combine traction with injectable treatments or surgery without explicit urological guidance.

Penile traction devices are available without a prescription in most countries. However, medical consultation before beginning treatment is strongly recommended, especially for men with Peyronie's disease, post-surgical shortening, or underlying health conditions. A urologist can confirm appropriate candidacy, rule out contraindications, and help establish a treatment protocol tailored to your clinical indication.

Penile traction devices — often marketed as penis extenders or penis stretchers — differ in tension range, comfort system, materials, and regulatory status. Medical-grade devices from Danamedic, including SizeGenetics, MaleEdge, and Jes-Extender, deliver up to 2,800 grams of calibrated tension with 58-way Multi-Axis Comfort Technology. Unregulated devices often lack calibrated tension settings, use inferior materials, and carry no clinical validation. For a comprehensive comparison, see choosing the right penile traction device.

Choose a penile traction device based on three criteria: (1) regulatory status — look for FDA-registered Class II medical device clearance via 510(k); (2) adjustable, calibrated tension — the device must deliver measurable force within the clinically validated range of 900–2,800 grams; (3) comfort system — extended 4–6 hour daily wear requires proper padding and multi-axis adjustment. Danamedic manufactures the only devices used in the published clinical studies.

Medical-grade penile traction devices typically cost between $150–$500 depending on the model and included accessories. SizeGenetics offers a 6-month money-back guarantee, allowing patients to evaluate results over a full clinical treatment cycle before committing financially. When compared to surgical alternatives costing $5,000–$15,000 with permanent risks, traction therapy represents a substantially lower-cost, lower-risk first-line option.

No — homemade traction devices and hanging weights pose serious injury risks. DIY devices cannot deliver calibrated, controlled tension. Without proper tension limiters, force distribution, and medical-grade materials, improvised devices can cause tissue damage, circulatory problems, or nerve injury. Every clinical study demonstrating safe, effective penile traction therapy used professionally manufactured, calibrated medical devices — not improvised equipment.

Start at the lower end of the therapeutic range — approximately 900–1,200 grams — and increase gradually over 2–4 weeks as tissues adapt. Clinical studies used tensions up to 2,800 grams, with the maximum rated force across all Danamedic brands reaching 3,200 grams. Your optimal tension depends on comfort tolerance and tissue response. Never increase tension to the point of pain — discomfort indicates excessive force.

Initial measurable changes typically appear at 8–12 weeks of consistent daily use. Clinical studies measured final outcomes at 3–6 months. Toussi et al. (PMID: 34060339) documented statistically significant results at 3 months (1.6 cm vs 0.3 cm, p<0.01). Gontero et al. (PMID: 19138361) measured outcomes at 6 months. Patience and daily protocol adherence are essential — the biological process of tissue growth through mechanotransduction requires sustained, consistent stimulation.

Published evidence indicates gains are durable. Penile traction therapy produces actual cellular proliferation and tissue remodeling — not temporary stretching. Gontero et al. (PMID: 19138361) confirmed maintained gains at 6-month follow-up, and Nikoobakht et al. (PMID: 20102448) documented preserved length in both flaccid and stretched states. Some practitioners recommend a brief maintenance protocol after the primary treatment phase to consolidate results. Long-term follow-up data beyond 12 months remains limited in the current literature. For the full evidence base, see clinical studies and evidence for penile traction therapy.

Clinical response varies by individual. In the Toussi RCT, the treatment group achieved significantly greater gains than controls, but individual results ranged. If adequate gains are not achieved after 3–6 months of consistent use at therapeutic tension levels, consult a urologist to evaluate contributing factors. SizeGenetics includes a 6-month money-back guarantee, providing financial protection over a full treatment cycle. Alternative options include surgical consultation for persistent cases.

Realistic length gains from penile traction therapy are 1.3–2.3 cm (0.5–0.9 inches) over 3–6 months, based on published clinical data. The Almsaoud 2023 meta-analysis (PMID: 36895692) confirmed a weighted mean of 1.9 cm across 12 studies. Nikoobakht et al. reported 1.7 cm; Toussi et al. reported 1.6 cm in the treatment group. Claims of gains exceeding 3–4 cm are not supported by peer-reviewed evidence and should be treated with skepticism. For the complete evidence base, see does penile traction therapy really work.

Penile traction therapy is primarily validated for length gains. Published clinical studies, including the Almsaoud meta-analysis (PMID: 36895692), primarily measured length as the outcome variable; no consistent girth gains have been demonstrated across pooled data. The mechanism of mechanotransduction primarily acts along the axis of applied force, which in traction devices is longitudinal. Men seeking primarily girth enhancement should discuss alternative options with a urologist.

For men researching safe penis enlargement methods, penile traction therapy is the safest evidence-based method for non-surgical penile lengthening. With no serious adverse events reported across 15+ peer-reviewed studies and over 1,000 patients, medical-grade traction devices demonstrate a well-tolerated safety profile. Compared to surgery (which carries risks of scarring, shortening, and erectile dysfunction) or unproven pills and supplements, traction therapy offers the best balance of documented effectiveness and safety. For the full clinical safety analysis, see penile traction therapy safety and side effects.